Does CONESTAT ALFA Cause Product dose omission issue? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Product dose omission issue have been filed in association with CONESTAT ALFA (Ruconest). This represents 3.1% of all adverse event reports for CONESTAT ALFA.
46
Reports of Product dose omission issue with CONESTAT ALFA
3.1%
of all CONESTAT ALFA reports
0
Deaths
10
Hospitalizations
How Dangerous Is Product dose omission issue From CONESTAT ALFA?
Of the 46 reports, 10 (21.7%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CONESTAT ALFA. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does CONESTAT ALFA Cause?
Intentional product use issue (227)
Condition aggravated (166)
Weight fluctuation (125)
Product use in unapproved indication (97)
Drug ineffective (94)
Vascular access site complication (90)
Underdose (74)
Weight decreased (74)
Weight increased (74)
Insurance issue (48)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which CONESTAT ALFA Alternatives Have Lower Product dose omission issue Risk?
CONESTAT ALFA vs COPANLISIB
CONESTAT ALFA vs COPAXONE
CONESTAT ALFA vs COPEGUS
CONESTAT ALFA vs COPPER
CONESTAT ALFA vs CORDARONE